Fact sheet 2008
| Chairman and CEO | Daniel Vasella, M.D. |
| Headquarters | Basel, Switzerland |
| Major R&D sites | Basel, Switzerland |
| Cambridge, Massachusetts | |
| East Hanover, New Jersey | |
| Horsham, England | |
| Shanghai, China |
| Major production sites | Basel, Switzerland |
| Grimsby, England | |
| Huningue, France | |
| Kundl, Austria | |
| Kurtkoy, Turkey | |
| Lincoln, Nebraska | |
| Ringaskiddy, Ireland | |
| Schaftenau, Austria | |
| Schweizerhalle, Switzerland | |
| Singapore | |
| Stein, Switzerland | |
| Suffern, New York |
| Web site address | www.novartis.com |
| Stock exchange listings | SIX Swiss Exchange, traded on SWX Europe (NOVN.VX) |
| New York Stock Exchange (NVS) |
| 2008 net sales | USD 41.5 billion |
| 2008 R&D spending | USD 7.2 billion |
| 2008 full-time associates | total 96 717 |
Get Novartis Media Releases through RSS
Stay Connected
Receive updates on company news and announcements.
